表紙
市場調査レポート

中国の漢方売薬業界レポート

China Chinese Patent Medicine Industry Report, 2013-2016

発行 ResearchInChina 商品コード 172262
出版日 ページ情報 英文 102 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
中国の漢方売薬業界レポート China Chinese Patent Medicine Industry Report, 2013-2016
出版日: 2014年03月07日 ページ情報: 英文 102 Pages
概要

中国の漢方売薬業界は、2010年から2013年において急速に拡大しており、その収益は2010年の2154億人民元から、2013年には4482億人民元へとCAGRで27.7%の成長となりました。

当レポートでは、中国の漢方売薬業界について調査分析し、業界政策、発展状況、地域市場、輸出入、発展動向について検証するほか、原材料の状況、セグメント別市場分析、主要企業プロファイルなども含めて、概略以下の構成でお届けいたします。

第1章 漢方売薬の概要

  • 定義と機能
  • 分類

第2章 漢方売薬業界の操業環境

  • 政策
  • 消費動向
  • 業界動向

第3章 漢方売薬業界の市場

  • 発展状況
  • 需要と供給
  • 輸出入
  • 需要動向
  • 伝統的な漢方薬(TCM)の原材料
  • 植物エキス

第4章 中国の漢方売薬市場セグメント

  • 概要
  • 心血管疾患、脳血管疾患
  • 腫瘍性疾患
  • 呼吸器系疾患
  • 筋骨格系疾患

第5章 漢方売薬の主要な製造業者

  • Tianjin Tasly Pharmaceutical Co., Ltd.
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
  • Shandong Dong-E E-Jiao Co., Ltd.
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
  • Shanghai Kaibao Pharmaceutical Co., Ltd.
  • Kangmei Pharmaceutical Co., Ltd.
  • Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
  • Beijing Tongrentang Co., Ltd. (TRT)

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: ZZR-001

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales.

Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China's Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%.

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million. The representative products include ginkgo leaf injection, Shuxuetong injection, Danhong injection, Xingnao injection, and more.

Demand Structure of Chinese Patent Medicine by disease or dosage forms

Source: China Chinese Patent Medicine Industry Report,
2013-2016, ResearchInChina

In the international market, there is a higher recognition of Chinese patent medicine in Asia, especially in Southeast Asia, and many varieties of Chinese patent medicine are included in the Medicare drug list stipulated by Southeast Asian countries, and special departments are established for management research as well. But in the U.S. and European markets, affected by access restrictions and differences in medical health concept, Chinese patent medicine is still only sold as health care product. However, the international market sees strong demand for plant extracts (mostly traditional Chinese medicinal materials) whose export value in 2010-2013 grew at a CAGR of 44% and accounted for approximately 50% of China's TCM export value.

China Chinese Patent Medicine Industry Report, 2013-2016 mainly covers the followings:

  • Introduction to China's Chinese patent medicine industry chain as well as domestic and foreign policies, consumer trends and industry trends;
  • Development situation, supply and demand, import and export, regional analysis, industry chain segments, etc. of Chinese patent medicine industry;
  • China's Chinese patent medicine market segments, involving Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, etc.;
  • Profile and analysis, development prospect and earnings forecast, industry trends and market forecast of key Chinese patent medicine manufacturers in China.

Table of Contents

1. Overview of Chinese Patent Medicine

  • 1.1. Definition and Characteristics
  • 1.2. Classification
    • 1.2.1. Classification by Dosage Form
    • 1.2.2. Classification by Pharmacology
    • 1.2.3. Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry

  • 2.1. Policies
    • 2.1.1. Domestic Policies
    • 2.1.2. Foreign Policies
  • 2.2. Consumer Trends
  • 2.3. Industry Trends

3. Chinese Patent Medicine Market

  • 3.1. Development Status
  • 3.2. Demand
    • 3.2.1. Regional Demand
    • 3.2.2. Product Demand Structure
    • 3.2.3. Trends
  • 3.3. Supply
    • 3.3.1. Yield Analysis and Key Areas
    • 3.3.2. Industry Concentration
  • 3.4. Regional Analysis of Players
  • 3.5. Import and Export
    • 3.5.1. Import
    • 3.5.2. Export
    • 3.5.3. Import-Export Structure
  • 3.6. Traditional Chinese Medicinal Materials
    • 3.6.1. Resources
    • 3.6.2. Price Trend
  • 3.7. Traditional Chinese Medicine Decoction Pieces (Chinese Herbal Medicines for Primary Processing)
    • 3.7.1. Industry Status
    • 3.7.2. Industry Trends
  • 3.8. Plant Extract
    • 3.8.1. Development Status
    • 3.8.2. Import and Export

4. Chinese Patent Medicine Market Segments in China

  • 4.1. Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • 4.2. Chinese Patent Medicine for Tumor Diseases
  • 4.3. Chinese Patent Medicine for Respiratory System Diseases
  • 4.4. Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Enterprises

  • 5.1. Tianjin Tasly Pharmaceutical Co., Ltd.
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. Prospects
  • 5.2. Guizhou Yibai Pharmaceutical Co., Ltd.
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Revenue Structure
    • 5.2.4. Gross Margin
    • 5.2.5. Prospects
  • 5.3. Yunnan Baiyao Group Co., Ltd.
    • 5.3.1. Profile
    • 5.3.2. Operation
    • 5.3.3. Revenue Structure
    • 5.3.4. Gross Margin
    • 5.3.5. Prospects
  • 5.4. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
    • 5.4.1. Profile
    • 5.4.2. Operation
    • 5.4.3. Revenue Structure
    • 5.4.4. Gross Margin
    • 5.4.5. Prospects
  • 5.5. Shandong Dong-E E-Jiao Co., Ltd.
    • 5.5.1. Profile
    • 5.5.2. Operation
    • 5.5.3. Revenue Structure
    • 5.5.4. Gross Margin
    • 5.5.5. Prospects
  • 5.6. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
    • 5.6.1. Profile
    • 5.6.2. Operation
    • 5.6.3. Revenue Structure
    • 5.6.4. Gross Margin
    • 5.6.5. Prospects
  • 5.7. Shanghai Kaibao Pharmaceutical Co., Ltd.
    • 5.7.1. Profile
    • 5.7.2. Operation
    • 5.7.3. Revenue Structure
    • 5.7.4. Gross Margin
    • 5.7.5. Prospects
  • 5.8. Kangmei Pharmaceutical Co., Ltd.
    • 5.8.1. Profile
    • 5.8.2. Operation
    • 5.8.3. Revenue Structure
    • 5.8.4. Gross Margin
    • 5.8.5. Prospects
  • 5.9. Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
    • 5.9.1. Profile
    • 5.9.2. Operation
    • 5.9.3. Revenue Structure
    • 5.9.4. Gross Margin
    • 5.9.5. Prospects
  • 5.10. Beijing Tongrentang Co., Ltd. (TRT)
    • 5.10.1. Profile
    • 5.10.2. Operation
    • 5.10.3. Revenue Structure
    • 5.10.4. Gross Margin
    • 5.10.5. Prospects

6. Summary and Forecast

  • 6.1. Comparison of Domestic Key Chinese Patent Medicine Enterprises
    • 6.1.1. Revenue
    • 6.1.2. Gross Margin
  • 6.2. Industry Forecast
    • 6.2.1. Industry Trends
    • 6.2.2. Market Forecast

Selected Charts:

  • Advantages and Disadvantages of Chinese Patent Medicine
  • Classification of Chinese Patent Medicine by Dosage Form
  • Classification of Chinese Patent Medicine by Pharmacology
  • Chinese Patent Medicine Industry Chain
  • Recent National Policies on Chinese Patent Medicine
  • Chinese herbal medicine production support projects, 2013
  • Percentage of Chinese Patent Medicine Output Value in Total Output Value of Pharmaceutical Industry, 2009-2012
  • Number of Chinese Patent Medicine Enterprises in China, 2010-2013
  • Revenue and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
  • Total Profit and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
  • Gross Margin of Chinese Patent Medicine Enterprises in China, 2012-2013
  • China's Top 7 Regions by Chinese Patent Medicine Sales, 2012
  • China's Chinese Patent Medicine Sales Structure by Top 7 Regions, 2012
  • China's Chinese Patent Medicine Hospital Terminal Sales Structure by Type of Diseases Treated, 2012
  • Revenue and Share in Pharmaceutical Industry of China's Chinese Patent Medicine Industry, 2010-2013
  • China's Population Aged 65 and Above, 2002-2013
  • Per Capita Healthcare Expenditure of China's Urban and Rural Residents, 2002-2012
  • Average Annual Air Pollution Index in Some Key Cities Nationwide, 2013
  • Output and YoY Growth Rate of Chinese Patent Medicine in China, 2010-2013
  • China's Top 5 Regions by Chinese Patent Medicine Output, 2013
  • Market Share Ranking of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • Market Share Ranking of Chinese Patent Medicine for Tumor Diseases
  • Market Share Ranking of Chinese Patent Medicine for Musculoskeletal Diseases
  • Market Share Ranking of Gynecological Products
  • Top 10 Chinese Provinces/Municipalities by Number of Above-scale Chinese Patent Medicine Enterprises, 2012
  • Top 10 Chinese Provinces/Municipalities by Sales of Chinese Patent Medicine Enterprises, 2012
  • Chinese Provinces/Municipalities with Gross Margin of Chinese Patent Medicine Enterprises Above 40%, 2012
  • Number of Enterprises, Sales and Total Profit of China's Chinese Patent Medicine Market by Region, 2012
  • China's Chinese Patent Medicine Import Value and YoY Growth Rate, 2010-2013
  • China's Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Import Value and YoY Growth Rate, 2010-2013
  • China's Plant Extract Import Value and YoY Growth Rate, 2010-2013
  • China's Chinese Patent Medicine Export Value and YoY Growth Rate, 2010-2013
  • China's Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Export Value and YoY Growth Rate, 2010-2013
  • China's Plant Extract Export Value and YoY Growth Rate, 2010-2013
  • Proportion of Export Value of China's Plant Extracts in TCM Commodities, 2010-2013
  • TCM Commodities Export Value by Region, Jan-Sep 2013
  • China's Top 10 Chinese Patent Medicine Exporting Enterprises, 2011
  • China's Top 5 Chinese Patent Medicine Exporting Enterprises, 2012
  • Trade Gap between China's Chinese Patent Medicine Imports and Exports, 2010-2013
  • Proportion of China's Plant Extract Export Value, 2010-2013
  • Trend Chart of Traditional Chinese Medicinal Material Comprehensive 200 Index, 2007-2013
  • Price Index of Traditional Chinese Medicinal Materials in Chengdu, China, 2010-2013
  • Major Traditional Chinese Medicinal Material GAP Enterprises in China, 2012
  • Revenue and Net Income of Traditional Chinese Medicine Decoction Pieces Industry, 2010-2013
  • China's Plant Extract Export Destination Structure by Export Value, 2012
  • Four Major Series of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • Share of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
  • Excellent Brands of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
  • Share of Chinese Patent Medicine for Tumor Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Tumor Diseases in Some Key Cities, 2012
  • Top 10 Excellent Brands of Chinese Patent Medicine for Tumor Diseases in China, 2012
  • Share of Chinese Patent Medicine for Respiratory System Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Chinese Patent Medicine for Respiratory System Diseases in Sample Hospital by Type, 2012
  • Excellent Brands of Chinese Patent Medicine for Respiratory System Diseases, 2012
  • Share of Chinese Patent Medicine for Musculoskeletal Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Musculoskeletal Diseases in Sample Hospital, 2012
  • China's Top 10 Excellent Brands of Traditional Chinese Medicine for Musculoskeletal Diseases, 2012
  • Revenue and Net Income of Tasly, 2010-2013
  • Revenue Breakdown of Tasly by Sector, 2010-2013
  • Revenue Breakdown of Tasly by Region, 2010-2013
  • Gross Margin of Tasly by Sector, 2010-2013
  • Gross Margin of Tasly by Region, 2010-2013
  • Revenue and Net Income of Tasly, 2012-2016E
  • Revenue and Net Income of Yibai Pharmaceutical, 2010-2013
  • Revenue Breakdown of Yibai Pharmaceutical by Product, 2010-2013
  • Gross Margin of Yibai Pharmaceutical by Product, 2010-2013
  • Revenue and Net Income of Yibai Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Yunnan Baiyao, 2010-2013
  • Revenue Breakdown of Yunnan Baiyao by Product, 2010-2013
  • Revenue Breakdown of Yunnan Baiyao by Region, 2010-2013
  • Gross Margin of Yunnan Baiyao by Product, 2010-2013
  • Gross Margin of Yunnan Baiyao by Region, 2010-2013
  • Revenue and Net Income of Yunnan Baiyao, 2012-2016E
  • Revenue and Net Income of Pien Tze Huang, 2010-2013
  • Revenue Breakdown of Pien Tze Huang by Sector, 2010-2013
  • Revenue Breakdown of Pien Tze Huang by Region, 2010-2013
  • Gross Margin of Pien Tze Huang by Product, 2010-2013
  • Gross Margin of Pien Tze Huang by Region, 2010-2013
  • Revenue and Net Income of Pien Tze Huang, 2012-2016E
  • Revenue and Net Income of Dong-E E-Jiao, 2010-2013
  • Revenue Breakdown of Dong-E E-Jiao by Product, 2010-2013
  • Revenue Breakdown of Dong-E E-Jiao by Region, 2010-2013
  • Gross Margin of Dong-E E-Jiao by Product, 2010-2013
  • Gross Margin of Dong-E E-Jiao by Region, 2010-2013
  • Revenue and Net Income of Dong-E E-Jiao, 2012-2016E
  • Revenue and Net Income of CR Sanjiu, 2010-2013
  • Revenue Breakdown of CR Sanjiu by Sector, 2010-2013
  • Revenue Breakdown of CR Sanjiu by Product, 2010-2013
  • Gross Margin of CR Sanjiu by Sector, 2010-2013
  • Revenue and Net Income of CR Sanjiu, 2012-2016E
  • Revenue and Net Income of Shanghai Kaibao, 2010-2013
  • Revenue Breakdown of Shanghai Kaibao by Product, 2010-2013
  • Revenue Breakdown of Shanghai Kaibao by Region, 2010-2013
  • Gross Margin of Shanghai Kaibao by Product, 2010-2013
  • Revenue and Net Income of Shanghai Kaibao, 2012-2016E
  • Revenue and Net Income of Kangmei Pharmaceutical, 2010-2013
  • Revenue Breakdown of Kangmei Pharmaceutical by Product, 2010-2013
  • Gross Margin of Kangmei Pharmaceutical by Product, 2010-2013
  • Revenue and Net Income of Kangmei Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2010-2013
  • Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
  • Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
  • Gross Margin of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
  • Gross Margin of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
  • Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Tongrentang, 2010-2013
  • Revenue Breakdown of Tongrentang by Region, 2010-2013
  • Gross Margin of Tongrentang by Region, 2010-2013
  • Revenue and Net Income of Tongrentang, 2012-2016E
  • Revenue of Some Key Chinese Patent Medicine Enterprises in China, Jan-Sep 2013
  • Gross Margin of Some Key Chinese Patent Medicine Enterprises in China, Jan-Jun 2013
  • Revenue of Chinese Patent Medicine Industry in China, 2013-2016E
Back to Top